Michael Skynner - 02 Jul 2026 Form 4 Insider Report for BICYCLE THERAPEUTICS PLC (BCYC)

Reporting relationship: CHIEF SCIENTIFIC OFFICER
Issuer ticker: BCYC
Reported as of: 02 Jul 2026
Net transaction value: -$10,231
SEC form: 4
Accepted by SEC: 07 Jul 2026, 17:00:14 UTC
Prior SEC filing: 06 Apr 2026
Next SEC filing: 17 Jul 2026
Source filing: View source filing
Reporting owner signature: /s/ Travis Thompson, Attorney-in-Fact

Key filing fact

Michael Skynner filed Form 4 for BICYCLE THERAPEUTICS PLC (BCYC) on 07 Jul 2026.

Key facts

This page summarizes Michael Skynner's Form 4 filing for BICYCLE THERAPEUTICS PLC (BCYC).
2 reported transactions and 0 derivative rows are listed below.
Accepted by SEC: 07 Jul 2026, 17:00.

Change

Previous filing in this sequence was filed on 06 Apr 2026.
Current net transaction value: -$10,231.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001776582 Primary reporting owner

Skynner Michael

Relationship: CHIEF SCIENTIFIC OFFICER
Address: C/O BICYCLE THERAPEUTICS PLC, BLOCKS A & B, PORTWAY BUILDING, CAMBRIDGE, UNITED KINGDOM
Signature: /s/ Travis Thompson, Attorney-in-Fact
Signature date: 07 Jul 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

BCYC transaction

Ordinary Shares

Sale

Transaction value: $7,938
Shares: -1,859
Change %: -1.2%
Price: $4.27
Shares after: 157,703
Date: 02 Jul 2026
Ownership: Direct
Footnotes: F1, F2

BCYC transaction

Ordinary Shares

Sale

Transaction value: $2,293
Shares: -532
Change %: -0.34%
Price: $4.31
Shares after: 157,171
Date: 06 Jul 2026
Ownership: Direct
Footnotes: F1, F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the vesting and settlement of the RSUs. This sale is mandated by the Reporting Person's award agreement that requires the satisfaction of minimum statutory tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary sale by the Reporting Person.

Footnote F2

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.26 to $4.29 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3).

Footnote F3

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.30 to $4.31 inclusive.